Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EPI-589, a quinone derivative and oxidoreductase enzyme inhibitor, is considered safe and well tolerated, showing promise for the treatment of amyotrophic lateral sclerosis (ALS).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 46.00 |
Description | EPI-589, a quinone derivative and oxidoreductase enzyme inhibitor, is considered safe and well tolerated, showing promise for the treatment of amyotrophic lateral sclerosis (ALS). |
Targets&IC50 | Oxidoreductase enzyme: |
In vivo | EPI-589 significantly enhances biomarkers in cerebrospinal fluid (CSF) and plasma associated with neuroinflammation and ALS disease progression. |
Molecular Weight | 265.31 |
Formula | C14H19NO4 |
CAS No. | 1147883-03-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EPI-589 1147883-03-1 Others EPI 589 EPI589 inhibitor inhibit